AxoGen (AXGN)
(Delayed Data from NSDQ)
$12.67 USD
-0.42 (-3.21%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.66 -0.01 (-0.08%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AXGN 12.67 -0.42(-3.21%)
Will AXGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AXGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AXGN
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
AXGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
Other News for AXGN
Axogen (AXGN) Considers Potential Sale Amid Acquisition Interest
Axogen gains on report of takeover interest
AxoGen exploring possible sale after approach, Street Insider says
Axogen (AXGN) Considers Potential Sale Amid Takeover Proposal
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference | AXGN Stock News